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Introduction: In cardiovascular research, there has recently been an 
interest in ultra-high field MRI to characterize cardiac anatomy and function 
in rodents. However, reports on the accuracy of the method are scarce. The 
purpose of our work was to evaluate left ventricular (LV) systolic function in 
a mouse model of cardiac hypertrophy using an 11.7T MRI machine and to 
assess the validity of our results by comparing them with ex vivo measure-
ments.
Methods: 24 C57Bl/6J mice were studied, including 11 animals having 
undergone a surgical transverse aortic constriction (TAC) and 13 sham ani-
mals. Imaging was performed on a 11.7 Tesla Bruker MR scanner. The LV 
systolic function was assessed from a stack of 1mm thick short-axis views 
obtained with a FLASH-cine sequence covering the entire ventricles. Using a 
dedicated software (SegmentTM, Medviso, Sweden), the following volumes 
(μl) were determined: end-diastolic, end-systolic and stroke volumes. LV ejec-
tion fraction (in %) and LV mass (mg) were subsequently deduced. One week 
after, mice were sacrificed and their LV mass and tibial length (TL) were 
measured.
Results: As expected, LV mass was significantly higher in the TAC group. 
When using the previously validated LV mass/tibial length ratio (LV/TL), 
sham mice showed a ratio of 4.65±0.09mg/mm and 3.83±0.11mg/mm for 
morphometric and MRI measurements respectively, and TAC mice showed a 
ratio of 6.50±0.40 and 5.39±0.28 respectively (p<0.05). Systolic dysfunction 
was highlighted in the TAC group, with a reduced LVEF of 40,64±4,37% 
(p<0.05). We demonstrated an excellent correlation between LV mass mea-
surements by weighing or imaging, with a Pearson correlation (r) of 0.92 for 
both LV mass and LV/TL ratio (p<0.05, Fig.).
Conclusion: High-field cardiac MRI is a promising tool to assess and 
follow LV systolic function and hypertrophy in mouse models of cardiovas-
cular diseases. In this study, compared with ex vivo measurements, MRI 
showed similar differences between our experimental groups.
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Introduction: Magnetic Resonance (MR) allows non invasive character-
ization of cardiac structure, function and metabolism. Fundamental studies are 
usually performed on isolated rodent heart. In order to provide a model closer 
to human heart, we present a MR-compatible isolated working heart system 
for large animals.
Methods: Hearts from pigs were perfused ex vivo in a working mode with 
a mixture of blood and Tyrode. MR acquisition sequences were performed at 
1.5T with ECG triggering and using standard clinical hardware. Cine short 
axis images were acquired to calculate ejection fraction (EF), and myocardial 
tissue alterations were assessed from parametric T1-maps (Look-locker 
method). Intraventricular pressures were recorded continuously and cardiac 
pacing was tested for inducing arrhythmia.
Results: During perfusion, heart rate increased from 90 to 120 bpm asso-
ciated with a reduction of the diastolic filling period and a progressive altera-
tion of the mechanical function: decrease in dP/dtmax (–20%) and aortic flow 
(–25%) with an EF at 20%. T1-maps showed a spatially homogeneous distri-
bution over the myocardium in a normal heart, while variations on anterior 
and posterior faces were reported on a pathological heart corresponding to 
observable ischemic area. Tagging, coronary artery imaging sequences were 
also performed to supplement assessment of cardiac function and structure. 
Ventricular tachycardia was induced by pacing at 120 to 180 bpm during MR 
acquisitions without image degradation.
Conclusions: We successfully performed blood-perfusion of isolated pig 
hearts with working left atrium and ventricle inside a MR environment, 
allowing simultaneous assessment of cardiac structure, mechanics and electro-
physiology. This setup allows study of intrinsic mechanical, electrophysio-
logical and metabolic functions and their modifications under (patho)-
physiological conditions on animal heart close to the human heart, with car-
diac loads and metabolic supply control.
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Myocarditis, an inflammatory disease of the myocardium, is a major cause 
of death and dilated cardiomyopathy. However its work-up is not standardized 
due to the lack of reliable marker of progression. The disease is characterized 
by clusters of lymphoid and myeloid cell infiltrates, and endothelial activation 
which hallmark is the expression of adhesion molecules such as selectins. The 
aim of the study was to evaluate the ability of 99mTc-fucoidan, an imaging 
agent specific of selectins, in the assessment of inflammation in a model of 
experimental autoimmune myocarditis (EAM).
Methods: EAM has been induced in male Lewis rats with purified rat car-
diomyosin and compared with controls. The experiments were performed in the 
very early phase of myocarditis (10, 15 and 21 days after immunization) and 
included (1) quantification of 99mTc-fucoidan myocardial/lung ratio using 
SPECT/CT; (2) qualitatively: comparative analysis on adjacent slices of tracer 
uptake on autoradiography and selectins on immuno-histochemistry (CD62p, 
CD62e); and (3) quantitatively: relationship between 99mTc-fucoidan uptake by 
well counting (expressed as %ID/g of myocardium) and myocardial content of 
inflammatory cells (CD45; CD11b) using flow cytometry.
Results: myocardial uptake of 99mTc-fucoidan was significantly increased 
in EAM compared to controls (SPECT uptake ratio: 1.6±0.1 vs. 1.2±0.4, 
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